References
- Barrett K., Barman S., Boitano S., Brooks H. Ganong’s Review of Medical Physiology, 25th
edition, McGraw-Hill Education, 2016, 3-31.
- Bogiatzi, Chrysi, et al. “Metabolic Products of the Intestinal Microbiome and Extremes of
Atherosclerosis.” Atherosclerosis, vol. 273, 2018, 91–97.
- Brugère, Jean-François, et al. “Archaebiotics.” Gut Microbes, vol. 5 no. 1, 2013, 5–10.
- Clemente, Jose C., et al. “The Impact of the Gut Microbiota on Human Health: An
Integrative View.” Cell, vol. 148 no. 6, 2012, 1258–1270.
- “Heart Health Information: About Heart Disease.” Centers for Disease Control and
Prevention, Centers for Disease Control and Prevention, 2015.
- Jonsson, Annika Lindskog, and Fredrik Bäckhed. “Role of Gut Microbiota in
Atherosclerosis.” Nature Reviews Cardiology, vol. 14 no. 2, 2016, 79–87.
- Mayo Clinic Staff. “Arteriosclerosis / Atherosclerosis.” Mayo Clinic, 2018.
- “Statins: Are These Cholesterol-Lowering Drugs Right for You?” Mayo Foundation for
Medical Education and Research, Nov 2018.
- Tang, W.h. Wilson, et al. “Gut Microbiota in Cardiovascular Health and Disease.”
Circulation Research, vol. 120 no. 7, 2017, 1183–1196.
- Velasquez, Manuel, et al. “Trimethylamine N-Oxide: The Good, the Bad and the
Unknown.” Toxins, vol. 8 no. 11, 2016, 326.
